SEC Form 4 · accession 0001209191-18-061104
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew A. Hindman
Officer — Chief Business Officer
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 8:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 3, 2018 | S | 753 | $20.5556 | D | 5,171 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.